BridgeBio Oncology Therapeutics Inc. (BBOT) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

BridgeBio Oncology Therapeutics Inc. (BBOT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $673.7M, listed on NASDAQ, employing roughly 92 people, carrying a beta of 0.39 to the broader market. BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. Led by Pedro J. Beltran, public since 2025-08-12.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for BBOT as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →